| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cue Biopharma, Inc. | Director | Common Stock | 357 | $985 | $2.76 | Mar 23, 2023 | Direct |
| PIERIS PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 40K | Jun 21, 2023 | Direct | ||
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 24.4K | Jan 2, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| CUE | Cue Biopharma, Inc. | Mar 23, 2023 | 3 | -$2.9K | 4 | Mar 27, 2023 | Director |
| CUE | Cue Biopharma, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| CUE | Cue Biopharma, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
| CUE | Cue Biopharma, Inc. | Nov 15, 2021 | 6 | -$304K | 4 | Nov 17, 2021 | Director |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Jun 25, 2021 | 1 | $0 | 4 | Jun 29, 2021 | Director |